Vital Farms, Inc. (VITL) stock analysis
Close on Nov 12, 2026Market cap $385.10MP/E –Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed12 of 30 checks passed
Vital Farms passes 12 of the 30 checks behind our score; 7 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 3/6
- Past performance
- 3/6
- Financial health
- 5/6
- Dividend
- 0/6
What stands out
No debt
Vital Farms has no borrowings on its latest balance sheet.
Earnings grew over 5 years
Net income grew 49.8% a year on average over the last five fiscal years.
Revenue growing 10%+ a year
Revenue grew 28.0% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 263% a year over the last three fiscal years.
What to watch
Margin of safety under 20%
The price is 12.1% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $9.47 is above our fair value estimate of $8.45.
Return on equity under 15%
Return on equity was 0.1% over the last twelve months and averaged 12.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 0.1%, below the 10% that usually covers the cost of capital.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA above its 5-year median
Vital Farms's EV/EBITDA of 39.2 is above its 5-year median of 20.8.
P/B below the industry
Vital Farms's price-to-book of 1.43 is below the Food and Kindred Products median of 1.73.
Trading above fair value
The share price of $9.47 is above our fair value estimate of $8.45.
Margin of safety under 20%
The price is 12.1% above fair value, so there is no margin of safety.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 28.0% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 263% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -99.7% over the last twelve months, against a 5-year average of 49.8% a year.
Growing faster than the industry
Revenue grew 16.4% over the last twelve months; the Food and Kindred Products median is 1.4%.
Guidance lowered
Vital Farms lowered its fiscal year 2026 Net revenue outlook on May 7, 2026.
Gross margin slipping
Gross margin was 28.1% over the last twelve months, against 37.6% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 0.1% over the last twelve months and averaged 12.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 0.1%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Vital Farms's return on equity of 0.1% is above the Food and Kindred Products median of -15.0%.
Earnings grew over 5 years
Net income grew 49.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 0.0% over the last twelve months, against a 5-year average of 4.8%.
Net margin above the industry
Vital Farms's net margin of 0.0% is above the Food and Kindred Products median of -4.1%.
Financial health5/6
No debt
Vital Farms has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest not well covered
Operating income covers interest expense 0.3 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.10 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.01; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Vital Farms has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$8.45
The share price is 12% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 17.2× | 20.8× | 13.5× | $4.43 | 58% |
| P/B | 2.8× | 3.8× | 1.7× | $18.47 | 17% |
| Earnings power | 8.6% cost of equity | – | – | $11.15 | 25% |
| Fair value | $8.45 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 33.4
- Food and Kindred Products median 21.0
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $17.03M
- Value traded per 1% price move
- $5.73M
Downside
High risk
- Typical loss in a bad month
- 43.5%
- Volatility (annualized)
- 65%
- Sharpe ratio, 1 year
- -1.16
- Beta to the S&P 500 (5Y)
- 0.74
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +25.3% | +28.0% | +28.8% | – | |
| Gross profit | +24.2% | +37.7% | +30.8% | – | |
| Operating income | +39.1% | +247.6% | +48.5% | – | |
| Net income | +24.2% | +275.6% | +49.8% | – | |
| EPS, diluted | +22.0% | +263.4% | +39.8% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 11.7% | 21.4% | |
| Return on assets | – | 7.5% | 15.1% | |
| Current ratio | – | 5.30 | 2.16 | |
| Interest coverage | 16.0× | 25.1× | 101.1× | |
| Inventory turnover | – | 10.8× | 10.5× | |
| Capex to revenue | 1.8% | 4.8% | 10.8% | |
| Diluted shares | 35M | 33M | 46M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Vital Farms generated $175.23M from operations and spent $149.31M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 8.7% | 1.73× | 1.41× | 21.4% |
| FY2024 | 8.8% | 1.91× | 1.37× | 23.1% |
| FY2023 | 5.4% | 1.93× | 1.40× | 14.6% |
| FY2022 | 0.3% | 1.79× | 1.31× | 0.8% |
| FY2021 | 0.9% | 1.44× | 1.23× | 1.7% |
| FY2020 | 4.1% | 1.84× | 1.55× | 11.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$66.28M
- Cash generatingOperating cash flow above zero$33.72M
- Return on assets improvedROA up on the prior year19.4% → 18.4%
- Earnings backed by cashOperating cash flow above net income$33.72M vs $66.28M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose3.13 → 2.16
- No dilutionShare count did not rise45M → 46M
- Gross margin improvedGross margin up on the prior year37.92% → 37.62%
- More efficientAsset turnover rose2.20 → 2.11
See a number that looks wrong?